Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Roberto Salvia1, Fabio Casciani1, Elisabetta Sereni1

  • 1University of Verona Hospital Trust, The Pancreas Institute, Unit of General and Pancreatic Surgery, Verona, Italy.

Presse Medicale (Paris, France : 1983)
|March 18, 2019
PubMed
Summary

Recent medical treatments for localized pancreatic cancer show promising advancements. This chapter details the latest therapeutic strategies and their impact on patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transitional Type Circulating Tumor Cells Predict Systemic Recurrence and Support Risk Stratification for Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma: Long-term Outcomes of the CLUSTER Trial.

Annals of surgery·2025
Same author

7T MRI and histology reveal early tissue and perfusion changes after radiofrequency ablation in a murine colorectal cancer model.

Scientific reports·2025
Same author

An Antimicrobial Stewardship Program in Pancreatic Surgery Reduces the Infectious Risk of Colonized Bile, Reducing the Predictive Value of the Intraoperative Bile Culture: A Before-after Study on 1638 Pancreatoduodenectomies.

Annals of surgery·2025
Same author

Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study.

British journal of cancer·2025
Same author

Local ablation disrupts immune evasion in pancreatic cancer.

Cancer letters·2024
Same author

Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment.

JCO precision oncology·2024

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Pancreatic cancer remains a significant health challenge.
  • Localized disease offers potential for curative treatment.

Purpose of the Study:

  • To review the latest medical treatment advantages for localized pancreatic cancer.
  • To provide an overview of current therapeutic strategies.

Main Methods:

  • Literature review of recent clinical studies and trials.
  • Analysis of emerging treatment modalities and their efficacy.

Main Results:

  • Highlighting novel drug therapies and targeted treatments.
  • Discussing advancements in systemic therapies and supportive care.

Conclusions:

  • Recent advancements offer improved therapeutic options for localized pancreatic cancer.
  • Continued research is crucial for further enhancing treatment outcomes.

Related Experiment Videos